Phreesia filings document the company’s operating results, material agreements, capital structure and governance as a public healthcare technology company. Recent Form 8-K disclosures include quarterly financial results, stakeholder letters and earnings-call materials, along with material definitive agreements connected to credit facilities, acquisition financing and receivables arrangements.
The filing record also documents the completed AccessOne acquisition, the use and refinancing of related debt, and subsidiary arrangements involving AccessOne Funding and AccessOne MedCard. Governance disclosures include board composition changes, director compensation matters and shareholder-voting subjects, while capital-structure disclosures cover secured revolving credit, bridge-loan obligations and receivables purchase agreements.
Phreesia, Inc. (PHR) has filed a Form 144 indicating that shareholder Yvonne Hui intends to sell 307 common shares, worth about $8,371.83, through Fidelity Brokerage on or about 15 July 2025. With 59,504,269 shares outstanding, the planned sale represents roughly 0.0005% of the company’s float.
The filing also discloses that the same seller disposed of 4,208 shares over the past three months in six separate transactions, generating gross proceeds of approximately $104,610. The 307 shares being registered for sale were acquired on 11 July 2025 via restricted-stock vesting and constitute compensation-related stock.
The notice includes the standard certification that the seller is unaware of any non-public adverse information about Phreesia. Given the very small size relative to total shares outstanding and the routine nature of Rule 144 sales, this event is unlikely to be materially impactful for investors.